Local Chorus
Local news from local sources, read in your language.
Developing

Nobel medicine prize awarded to three scientists for optogenetics

🇷🇺 Russia, Stockholm 00:50 Science Business5 Tech3 Official2 updated 1 h ago first reported by Ведомости

In short

The 2026 Nobel Prize in Physiology or Medicine was awarded to Karl Deisseroth, Peter Hegemann and Georg Nagel for discoveries concerning light-sensitive ion channels and optogenetics, the Nobel Committee announced in Stockholm. The three share the 12 million kronor prize equally. The medicine prize opens this year's Nobel week.

Read the full story 2 min read

The Nobel Assembly at the Karolinska Institute has awarded the 2026 Nobel Prize in Physiology or Medicine to Karl Deisseroth, Peter Hegemann and Georg Nagel for discoveries concerning light-sensitive ion channels and optogenetics, the Nobel Committee announced in Stockholm on Monday, Interfax, Meduza, Vedomosti and Kommersant reported. The three share the prize equally, worth 12 million Swedish kronor (almost $1.2 million), according to Meduza and Vedomosti. The medicine prize is the first of this year's Nobel awards to be announced. [ 1 , 4 , 5 , 6 ]

Optogenetics is a method of controlling the physiological activity of a cell with light: a gene for a light-sensitive protein such as rhodopsin is introduced into a neuron, and after illumination the protein converts the light signal into a nerve impulse, Kommersant reported. Peter Hegemann and Georg Nagel discovered the protein channelrhodopsin in the single-celled alga Chlamydomonas in the early 2000s; under blue light it opens an ion channel and charged ions create an electrical impulse, Interfax and Vedomosti reported. Whatever cell the protein was placed in became light-sensitive, Vedomosti said. Habr News said Hegemann showed as early as 1991 that light causes ion currents in the cell through rhodopsin, and that in 2003 the two showed channelrhodopsin-2 is a directly light-controlled cation channel. [ 1 , 5 , 8 ]

Karl Deisseroth turned the protein into a light-controlled switch for nerve cells. He introduced the rhodopsin gene into rat nerve cells and, illuminating them with blue light, triggered a nerve signal, publishing the results in 2005; two years later he made the switch work in the brain of living mice, Interfax and Vedomosti reported. Meduza noted that optogenetics allows individual neurons to be stimulated precisely without affecting neighbouring cells, which direct electrical stimulation of the brain, known since the early 20th century, cannot do. [ 1 , 4 , 5 ]

The method is used in research on memory and stress — illuminating a mouse's brain through implanted optical fibres can recall a specific memory at a chosen moment, Meduza reported. Vedomosti said neural circuits behind particular memories, feelings and behaviour linked to neurological and psychiatric disorders have already been identified with it, and that it is being tried clinically to restore vision. Kommersant reported that in 2021 modified light-sensitive proteins were introduced into retinal ganglion cells, creating an artificial layer of light-sensitive cells in a blind retina; RBC's later explainer said optogenetics could help restore sight and advance treatment for Parkinson's patients. [ 4 , 5 , 6 , 9 ]

Last year's prize went to Mary Brunkow, Fred Ramsdell and Shimon Sakaguchi for research into peripheral immune tolerance, Meduza and Kommersant reported. Physics will be announced on 6 October, chemistry on 7 October, literature on 8 October and the peace prize in Oslo on 9 October, with the economics prize on 12 October, Meduza reported. The ceremony takes place on 10 December, the anniversary of Alfred Nobel's death. [ 4 , 6 ]

RIA Novosti later reported that a biologist described the laureates' discovery as a breakthrough. Outlets transliterate the names differently — Interfax wrote Дейссерот, TASS Дайссерот and Vedomosti Дайсерот. [ 1 , 3 , 5 , 10 ]

Why it matters

The award recognises a method that lets researchers switch neurons on and off with light and watch how nerve cells shape memory, feelings and behaviour in a living brain, according to the outlets. The documents also point to attempts to use it clinically, including restoring vision. Beyond the science, the announcement sets off the annual Nobel season, with physics, chemistry, literature, peace and economics prizes to follow.

Key facts

  • The 2026 Nobel Prize in Physiology or Medicine was awarded to Karl Deisseroth, Peter Hegemann and Georg Nagel. [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 ]
  • The Nobel Committee cited discoveries concerning light-sensitive ion channels and optogenetics. [ 1 , 4 , 5 , 6 , 8 ]
  • Hegemann and Nagel discovered the protein channelrhodopsin in the single-celled alga Chlamydomonas; blue light opens the channel and charged ions create an electrical impulse. [ 1 , 5 , 8 ]
  • Deisseroth introduced the rhodopsin gene into rat nerve cells, published the work in 2005 and two years later made the light-controlled switch work in the brains of living mice. [ 1 , 5 ]
  • The prize money is 12 million Swedish kronor, shared equally between the three laureates. [ 4 , 5 ]
  • The medicine prize is the first of this year's Nobel Prizes to be announced. [ 4 , 5 ]
  • The documents state that optogenetics is used in research on memory and stress and is being tried in clinical medicine to restore vision. [ 4 , 5 , 6 ]

Confirmed by several sources

  • The 2026 Nobel Prize in Physiology or Medicine was awarded to Karl Deisseroth, Peter Hegemann and Georg Nagel. [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 ]
  • The Nobel Committee cited the laureates for discoveries concerning light-sensitive ion channels and optogenetics. [ 1 , 4 , 5 , 6 , 8 ]
  • Hegemann and Nagel identified channelrhodopsin in the single-celled alga Chlamydomonas; blue light opens the ion channel and charged ions create an electrical impulse. [ 1 , 5 , 8 ]
  • Deisseroth introduced the rhodopsin gene into rat nerve cells, triggered a nerve signal with blue light, published the work in 2005 and two years later applied the light-controlled switch in the brains of living mice. [ 1 , 5 ]
  • The prize money is 12 million Swedish kronor, shared equally between the three laureates. [ 4 , 5 ]
  • The medicine prize is the first of this year's Nobel Prizes to be announced. [ 4 , 5 ]

Still unclear

  • Spelling of the laureates' names differs between outlets (Дейссерот, Дайссерот, Дайсерот; Хегеман and Хегеманн), as does the naming of the 2025 laureates (Мэри Бранков or Брунков, Симон or Шимон Сакагучи). The documents transliterate the names differently and give no single confirmed spelling.
  • The laureates' institutions are given as the Howard Hughes Medical Institute and Stanford University, Humboldt University of Berlin and the University of Würzburg. Single source (a tier-3 tech outlet); the other documents do not mention affiliations.
  • Possible clinical uses, including restoring vision and advancing treatment for Parkinson's disease. Vision restoration is mentioned by two outlets only in general terms, and the Parkinson's reference appears only in one RBC summary; the documents report no confirmed clinical results.

What local media are saying

Business mediaWire and business outlets carried detailed reports: the laureates and the citation, the 12 million kronor prize shared equally, explanations of how optogenetics works, the Nobel week schedule and possible medical applications. A later RBC piece focused on using light to control the nervous system and on restoring sight and treating Parkinson's patients. [ 1 , 2 , 4 , 5 , 6 , 9 ]
Official sourcesState outlets issued short announcements of the laureates and the citation, followed by an item quoting a biologist who called the discovery a breakthrough and a profile of the laureates. [ 3 , 7 , 10 , 11 ]
Technology mediaA tech outlet traced the research history, from Hegemann's 1991 work on how Chlamydomonas senses light to the characterisation of channelrhodopsins and channelrhodopsin-2 in 2003, and listed the laureates' institutions. [ 8 ]

Timeline, local time

  1. The medicine prize announcement was scheduled for no earlier than this time, Central European Summer Time, Vedomosti reported. [ 5 ]
  2. Interfax and RBC report the award of the 2026 Nobel Prize in Physiology or Medicine to Deisseroth, Hegemann and Nagel. [ 1 , 2 ]
  3. TASS reports the laureates. [ 3 ]
  4. Meduza reports the announcement in Stockholm and the citation. [ 4 ]
  5. Vedomosti reports the prize sum and the schedule for the rest of Nobel week. [ 5 ]
  6. Kommersant reports, describing optogenetics and its use in retinal research. [ 6 ]
  7. Habr News publishes a detailed timeline of the underlying research. [ 8 ]
  8. RBC publishes an explainer on applications including vision restoration and Parkinson's disease. [ 9 ]
  9. RIA Novosti reports a biologist describing the laureates' discovery as a breakthrough. [ 10 ]